223 related articles for article (PubMed ID: 33174200)
1. Biosynthesis, total synthesis, structural modifications, bioactivity, and mechanism of action of the quinone-methide triterpenoid celastrol.
Lu Y; Liu Y; Zhou J; Li D; Gao W
Med Res Rev; 2021 Mar; 41(2):1022-1060. PubMed ID: 33174200
[TBL] [Abstract][Full Text] [Related]
2. Potential medicinal value of celastrol and its synthesized analogues for central nervous system diseases.
Bai X; Fu RJ; Zhang S; Yue SJ; Chen YY; Xu DQ; Tang YP
Biomed Pharmacother; 2021 Jul; 139():111551. PubMed ID: 33865016
[TBL] [Abstract][Full Text] [Related]
3. Interrelated Mechanism by Which the Methide Quinone Celastrol, Obtained from the Roots of
Caruso F; Singh M; Belli S; Berinato M; Rossi M
Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33291769
[TBL] [Abstract][Full Text] [Related]
4. Cytochrome P450 catalyses the 29-carboxyl group formation of celastrol.
Zhou J; Hu T; Liu Y; Tu L; Song Y; Lu Y; Zhang Y; Tong Y; Zhao Y; Su P; Wu X; Huang L; Gao W
Phytochemistry; 2021 Oct; 190():112868. PubMed ID: 34273756
[TBL] [Abstract][Full Text] [Related]
5. Celastrol: Progresses in structure-modifications, structure-activity relationships, pharmacology and toxicology.
Hou W; Liu B; Xu H
Eur J Med Chem; 2020 Mar; 189():112081. PubMed ID: 31991334
[TBL] [Abstract][Full Text] [Related]
6. Biosynthesis and biotechnological production of the anti-obesity agent celastrol.
Zhao Y; Hansen NL; Duan YT; Prasad M; Motawia MS; Møller BL; Pateraki I; Staerk D; Bak S; Miettinen K; Kampranis SC
Nat Chem; 2023 Sep; 15(9):1236-1246. PubMed ID: 37365337
[TBL] [Abstract][Full Text] [Related]
7. Anti-inflammatory celastrol promotes a switch from leukotriene biosynthesis to formation of specialized pro-resolving lipid mediators.
Pace S; Zhang K; Jordan PM; Bilancia R; Wang W; Börner F; Hofstetter RK; Potenza M; Kretzer C; Gerstmeier J; Fischer D; Lorkowski S; Gilbert NC; Newcomer ME; Rossi A; Chen X; Werz O
Pharmacol Res; 2021 May; 167():105556. PubMed ID: 33812006
[TBL] [Abstract][Full Text] [Related]
8. Friedelane-type triterpene cyclase in celastrol biosynthesis from Tripterygium wilfordii and its application for triterpenes biosynthesis in yeast.
Zhou J; Hu T; Gao L; Su P; Zhang Y; Zhao Y; Chen S; Tu L; Song Y; Wang X; Huang L; Gao W
New Phytol; 2019 Jul; 223(2):722-735. PubMed ID: 30895623
[TBL] [Abstract][Full Text] [Related]
9. Identification of a cytochrome P450 from Tripterygium hypoglaucum (Levl.) Hutch that catalyzes polpunonic acid formation in celastrol biosynthesis.
Chen XC; Lu Y; Liu Y; Zhou JW; Zhang YF; Gao HY; Li D; Gao W
Chin J Nat Med; 2022 Sep; 20(9):691-700. PubMed ID: 36162954
[TBL] [Abstract][Full Text] [Related]
10. A Mechanistic Overview of Triptolide and Celastrol, Natural Products from
Chen SR; Dai Y; Zhao J; Lin L; Wang Y; Wang Y
Front Pharmacol; 2018; 9():104. PubMed ID: 29491837
[TBL] [Abstract][Full Text] [Related]
11. Molecular modulators of celastrol as the keystones for its diverse pharmacological activities.
Ng SW; Chan Y; Chellappan DK; Madheswaran T; Zeeshan F; Chan YL; Collet T; Gupta G; Oliver BG; Wark P; Hansbro N; Hsu A; Hansbro PM; Dua K; Panneerselvam J
Biomed Pharmacother; 2019 Jan; 109():1785-1792. PubMed ID: 30551432
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the Cytochrome P450 CYP716C52 in Celastrol Biosynthesis and Its Applications in Engineered
Lu Y; Liu Y; Zhang Y; Gao H; Chen X; Tu L; Luo Y; Jiang Z; Yin Y; Zhou J; Hu T; Wu X; Wang J; Gao W; Huang L
J Nat Prod; 2024 Feb; 87(2):176-185. PubMed ID: 38277488
[TBL] [Abstract][Full Text] [Related]
13. Celastrol as an emerging anticancer agent: Current status, challenges and therapeutic strategies.
Wang C; Dai S; Zhao X; Zhang Y; Gong L; Fu K; Ma C; Peng C; Li Y
Biomed Pharmacother; 2023 Jul; 163():114882. PubMed ID: 37196541
[TBL] [Abstract][Full Text] [Related]
14. Celastrol, a triterpene extracted from Tripterygium wilfordii Hook F, inhibits platelet activation.
Hu H; Straub A; Tian Z; Bassler N; Cheng J; Peter K
J Cardiovasc Pharmacol; 2009 Sep; 54(3):240-5. PubMed ID: 19661812
[TBL] [Abstract][Full Text] [Related]
15. Induction of the ER stress response in NRVMs is linked to cardiotoxicity caused by celastrol.
Chen Z; Zhuang Z; Meng C; Zhu Z; Zhang Y; Zhang Z
Acta Biochim Biophys Sin (Shanghai); 2022 Aug; 54(8):1180-1192. PubMed ID: 35983978
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic potential of demethylzeylasteral, a triterpenoid of the genus Tripterygium wilfordii.
Sun X; Shen B; Yu H; Wu W; Sheng R; Fang Y; Guo R
Fitoterapia; 2022 Nov; 163():105333. PubMed ID: 36244595
[TBL] [Abstract][Full Text] [Related]
17. Celastrol functions as an emerging manager of lipid metabolism: Mechanism and therapeutic potential.
Gu J; Shi YN; Zhu N; Li HF; Zhang CJ; Qin L
Biomed Pharmacother; 2023 Aug; 164():114981. PubMed ID: 37285754
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of celastrol derivatives as potential non-nucleoside hepatitis B virus inhibitors.
Zhang H; Lu G
Chem Biol Drug Des; 2020 Dec; 96(6):1380-1386. PubMed ID: 32573976
[TBL] [Abstract][Full Text] [Related]
19. The MVA pathway genes expressions and accumulation of celastrol in Tripterygium wilfordii suspension cells in response to methyl jasmonate treatment.
Liu YJ; Zhao YJ; Su P; Zhang M; Tong YR; Hu TY; Huang LQ; Gao W
J Asian Nat Prod Res; 2016 Jul; 18(7):619-28. PubMed ID: 26785825
[TBL] [Abstract][Full Text] [Related]
20. Celastrol: A Potential Natural Lead Molecule for New Drug Design, Development and Therapy for Memory Impairment.
Amir Yusri MA; Sekar M; Wong LS; Gan SH; Ravi S; Subramaniyan V; Mat Rani NNI; Chidambaram K; Begum MY; Ramar M; Safi SZ; Selvaraj S; Wu YS; Revathy P; Fuloria S; Fuloria NK; Lum PT; Djearamane S
Drug Des Devel Ther; 2023; 17():1079-1096. PubMed ID: 37064431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
